Egypt
Industry
In late 2009, BMI analysed the drug pricing amendment put forward by the Egyptian government. The implications for the local and multinational drugmakers in the country were far-reaching...
2010-05-14Industry
Egypt's government-owned Medical Insurance Authority is trying to reduce its massive budget deficit of US$31.2mn by increasing the price of subscriptions from EGP4 (US$0.73) to EGP8...
2010-04-23Industry
BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets....
2010-04-20Industry
We assert that Egypt's pharmaceutical sector has more potential in terms of growth and expansion prospects over the next five years than regional peers Algeria, Morocco. Our view...
2010-04-14Industry
The Egyptian government believes that counterfeit drugs in the country could be worth around US$181mn. It also estimates that 10% of medicines found in otherwise legal pharmacies...
2010-04-09Industry
The Egyptian pharmaceutical industry is growing steadily, with spending in this sector forecast to reach US$4.2bn by the end of 2014. With exports on the rise, we believe that the...
2010-03-11Industry
Healthcare spending in Egypt is expected to rise from US$8.51bn in 2009 to reach US$12.7bn by 2014, at a compound annual growth rate (CAGR) of 8.3% in US dollar terms and 4.3% in...
2010-03-08Industry
In BMI's recent analysis of the Gulf Co-operation Council (GCC) pharmaceutical market, we highlighted Saudi Arabia and the UAE as the biggest medicine spenders - reaching values of...
2010-02-05
